Meta-analysisindependent cross-checkabstract checked I-BAR-130 standard review

Meta-analysis: new alcohol problems after surgery

Rates of de novo alcohol use disorder and de novo high-risk alcohol use after bariatric surgery: a systematic review and meta-analysis.

Overview

Cheloff et al.. Surg Obes Relat Dis 2026 · PMID 42191444 · DOI 10.1016/j.soard.2026.03.030

About 2.5 in 100 developed new alcohol problems; the increase was clear after bypass but uncertain after sleeve.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

De novo AUD after MBS

How was the study done?

Meta-analysis

How many people, animals or samples were studied?

934,824

What was actually found?

2.49% overall

How large was the observed effect?

RYGB OR 1.81

What do the results mean in everyday life?

Alcohol risk mainly after bypass

What are the study's limitations?

Heterogeneous

What does it say about Elawady's specific claim?

Partly supports

Do the results apply to Germany and Europe?

Applicable

What can explicitly not be concluded from this study?

Sleeve-specific risk

Scientific in-depth review

1. Full reference

Authors
Cheloff et al.
Journal
Surg Obes Relat Dis
Year
2026
Identifier
PMID 42191444 DOI 10.1016/j.soard.2026.03.030
Verification
verified – PubMed efetch 2026-10-26 + Crossref API
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

What are the rates of de novo alcohol use disorder or high-risk alcohol use after bariatric surgery, and do they differ between RYGB and SG?

3. Study design and population

Study design
Meta-analysis – Systematic review and meta-analysis
Population

Patients after MBS

Country

Multinational

Period

Search to 23 March 2025

Sample size

54 studies, 934,824 patients

Inclusion and exclusion criteria

Studies reporting alcohol use after MBS

4. Methods and endpoints

Exposure / intervention

MBS (RYGB, SG, others)

Comparator

Pre-surgery; between procedures

Endpoints

De novo AUD / high-risk alcohol use

Statistical methods

Pooled event rates; meta-regression; GRADE and Newcastle-Ottawa

5. Actual results

Results

De novo AUD/high-risk use 2.49% (2.34-2.65) after any MBS; RYGB 1.48% vs SG 0.77% (differences not significant in direct comparisons). Odds increased post-surgery for RYGB (OR 1.81, 1.06-3.08) but not for SG (OR 0.67, 0.14-3.08) or other surgery.

Absolute risks

About 2.5 in 100 developed de novo AUD/high-risk alcohol use.

Authors' conclusion

De novo AUD and high-risk use appear to increase after both RYGB and SG, with no clear difference; interpretation limited.

6. Strengths

  • Very large, recent
  • Procedure comparison

7. Weaknesses

  • Heterogeneous outcomes
  • Mostly retrospective

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Abstract only.

9. Assessment of the statistical interpretation

SG pre-post OR 0.67 with very wide CI - inconclusive, not evidence of no effect.

10. Relevance to the specific claim

Confirms alcohol problems after surgery but shows the evidence for sleeve specifically is weaker than for bypass.

11. Independent contrary findings

12. Transferability to Germany and Europe

International.

13. Overall methodological judgement

Mixed: supports general claim, uncertain for sleeve.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Sleeve-specific AUD risk.

15. Linked fact checks